E-ISSN 2636-834X
 

Case Report 


Ketamine infusion in treatment resistant depression: a case report and brief review of the literature

Gökben Hızlı Sayar, Eylem Özten, Haluk A. Savaş.

Abstract
The glutamate N-methyl-D-aspartate (NMDA) receptor antagonist ketamine may exhibit antidepressant effect. Previous studies of treatment-resistant depression reveal that ketamine infusions may result in a rapid antidepressant response with improvement usually sustained for several days. This case suggests that intravenous administration of ketamine may be effective for immediate relief from symptoms in unipolar depression and may also relieve suicidal ideation. Due to the prolonged period between the initiation of treatment and the onset of action of currently available antidepressants, only a few things can be done for the management of acute and severe suicidal ideation other than close monitoring or hospitalization. Rapid effect of ketamine may be an advantage in the management of suicide risk. Although additional research is needed to ascertain optimal dosing schedules and route of administration of ketamine, NMDA agents warrant further investigation as a treatment option in treatment-resistant depression and as an agent intended to reduce suicides.

Key words: depression, ketamine, suicide, treatment resistance


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Gökben Hızlı Sayar
Articles by Eylem Özten
Articles by Haluk A. Savaş
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. PBS. 2015; 5(2): 78-82. doi:10.5455/jmood.20150130085334


Web Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. https://www.pbsciences.org/?mno=175165 [Access: December 16, 2023]. doi:10.5455/jmood.20150130085334


AMA (American Medical Association) Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. PBS. 2015; 5(2): 78-82. doi:10.5455/jmood.20150130085334



Vancouver/ICMJE Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. PBS. (2015), [cited December 16, 2023]; 5(2): 78-82. doi:10.5455/jmood.20150130085334



Harvard Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş (2015) Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. PBS, 5 (2), 78-82. doi:10.5455/jmood.20150130085334



Turabian Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. 2015. Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. Psychiatry and Behavioral Sciences, 5 (2), 78-82. doi:10.5455/jmood.20150130085334



Chicago Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. "Ketamine infusion in treatment resistant depression: a case report and brief review of the literature." Psychiatry and Behavioral Sciences 5 (2015), 78-82. doi:10.5455/jmood.20150130085334



MLA (The Modern Language Association) Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş. "Ketamine infusion in treatment resistant depression: a case report and brief review of the literature." Psychiatry and Behavioral Sciences 5.2 (2015), 78-82. Print. doi:10.5455/jmood.20150130085334



APA (American Psychological Association) Style

Gokben Hızlı Sayar, Eylem Ozten, Haluk A. Savaş (2015) Ketamine infusion in treatment resistant depression: a case report and brief review of the literature. Psychiatry and Behavioral Sciences, 5 (2), 78-82. doi:10.5455/jmood.20150130085334